SCHEMBL27438180

SCHEMBL27438180

Nc1ncnn2c([C@@H]3O[C@]4(CF)C(O[PH](=O)Oc5ccccc5)[C@]4(O)[C@H]3O)ccc12

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.38
▸ DOT1L Q8TEK3 1/20 0.32
▸ PRMT5 O14744 1/20 0.31
▸ WDR77 Q9BQA1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27438673 0.80 POLRMT (0.41) POLRMTDOT1L
SCHEMBL23844007 0.78 POLRMT (0.44) POLRMTDOT1L
SCHEMBL27438664 0.76 POLRMT (0.45) POLRMTDOT1L
SCHEMBL20960139 0.76 POLRMT (0.45) POLRMTDOT1LPRMT5WDR77
SCHEMBL27438153 0.75 BTN3A1 (0.35) POLRMTDOT1L
SCHEMBL23844099 0.75 POLRMT (0.37) POLRMTDOT1L
SCHEMBL27438284 0.75 POLRMT (0.34) POLRMTDOT1L
SCHEMBL23844060 0.74 CYP3A4 (0.39) POLRMTDOT1L
SCHEMBL27438235 0.74 POLRMT (0.35) POLRMTDOT1L
SCHEMBL23844094 0.73 POLRMT (0.42) POLRMTDOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030903-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2024-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030903-B2 Antiviral compounds EIF2AK2, MAVS, DUT POLRMT 76/4885DOT1L 653/4885PRMT5 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback